Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34272041

First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2021 Aug
First author
Emens LA

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2021 Oct;32(10):1308. doi: 10.1016/j.annonc.2021.07.013.
    note
    Source null
    related pmid
    34353668
    relationship
    Erratum in
  2. citation
    Ann Oncol. 2021 Dec;32(12):1650. doi: 10.1016/j.annonc.2021.10.002.
    note
    Source null
    related pmid
    34740469
    relationship
    Erratum in

Authors and identifiers

  1. name
    Emens LA
    type
    Author
  2. name
    Adams S
    type
    Author
  3. name
    Barrios CH
    type
    Author
  4. name
    Diéras V
    type
    Author
  5. name
    Iwata H
    type
    Author
  6. name
    Loi S
    type
    Author
  7. name
    Rugo HS
    type
    Author
  8. name
    Schneeweiss A
    type
    Author
  9. name
    Winer EP
    type
    Author
  10. name
    Patel S
    type
    Author
  11. name
    Henschel V
    type
    Author
  12. name
    Swat A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Emens LA
    type
    Author
  2. name
    Adams S
    type
    Author
  3. name
    Barrios CH
    type
    Author
  4. name
    Diéras V
    type
    Author
  5. name
    Iwata H
    type
    Author
  6. name
    Loi S
    type
    Author
  7. name
    Rugo HS
    type
    Author
  8. name
    Schneeweiss A
    type
    Author
  9. name
    Winer EP
    type
    Author
  10. name
    Patel S
    type
    Author
  11. name
    Henschel V
    type
    Author
  12. name
    Swat A
    type
    Author
bibliography ids
  1. nci-bib-ef2fb51fb87332917ed589ec
book metadata
content sha256
2e7dbba38acfe3fca590a29604be483c43d97c29f46d9d96ddcee8819c8fa8d1
document type
citation
dois
  1. 10.1016/j.annonc.2021.05.355
electronic publication date
display
2021 Jul 1
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34272041
immutable id
pubmed:34272041@2e7dbba38acfe3fca590a29604be483c43d97c29f46d9d96ddcee8819c8fa8d1
journal
abbreviation
Ann Oncol
issn electronic
1569-8041
issn print
0923-7534
issue
8
name
Annals of oncology : official journal of the European Society for Medical Oncology
nlm unique id
9007735
pages
983-993
volume
32
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2021 Oct;32(10):1308. doi: 10.1016/j.annonc.2021.07.013.
    note
    Source null
    related pmid
    34353668
    relationship
    Erratum in
  2. citation
    Ann Oncol. 2021 Dec;32(12):1650. doi: 10.1016/j.annonc.2021.10.002.
    note
    Source null
    related pmid
    34740469
    relationship
    Erratum in
outcomes validated
false
pmid
34272041
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
e8a30531c689c9f752453785a5ed3d18118e4abc360981b1b2c44607a10a022a
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Aug
precision
month
year
2021
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34272041/
title
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis.

Preserved source evidence · Not medical advice